SG Americas Securities’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-53,109	Closed	-$226K	–	3337
2025 Q4	$226K	Buy	+53,109	New	+$202K	﹤0.01%	2878
2024 Q2	–	Sell	-26,114	Closed	-$57K	–	2938
2024 Q1	$57K	Buy	+26,114	New	+$48.2K	﹤0.01%	2723
2022 Q2	–	Sell	-14,530	Closed	-$39K	–	3446
2022 Q1	$39K	Buy	14,530 +4,321	+42%	+$16.6K	﹤0.01%	2857
2021 Q4	$44K	Sell	10,209 -20,637	-67%	-$121K	﹤0.01%	3205
2021 Q3	$157K	Buy	30,846 +19,272	+167%	+$103K	﹤0.01%	3395
2021 Q2	$73K	Sell	11,574 -1,902	-14%	-$14.8K	﹤0.01%	2713
2021 Q1	$104K	Buy	+13,476	New	+$107K	﹤0.01%	3064
2020 Q4	–	Sell	-21,797	Closed	-$145K	–	3354
2020 Q3	$145K	Buy	21,797 +9,699	+80%	+$71.9K	﹤0.01%	2295
2020 Q2	$101K	Sell	12,098 -5,257	-30%	-$48.8K	﹤0.01%	3363
2020 Q1	$133K	Buy	+17,355	New	+$121K	﹤0.01%	2787
2018 Q3	–	Sell	-5,200	Closed	-$119K	–	3196
2018 Q2	$119K	Buy	+5,200	New	+$133K	﹤0.01%	2963
2016 Q4	–	Sell	-7,478	Closed	-$117K	–	3171
2016 Q3	$117K	Buy	+7,478	New	+$90.5K	﹤0.01%	2938